NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

Topic 6: Gastrointestinal And Genitourinary Systems: Selected Pathophysiology And Pharmacologic Therapy

Apr 7-13, 2022

Max Points:206

Objectives:

Describe normal pathophysiology and alterations of the gastrointestinal and genitourinary systems.
Integrate knowledge of pathophysiology and pharmacology into teaching and educational materials in diverse settings.
Describe a pharmacological intervention using an evidence-based treatment guideline.

Topic 6 DQ 1

Apr 7-9, 2022

Choose a medical condition from the gastrointestinal or genitourinary systems and explain the pathophysiology changes that may occur. What patient education would need to be included related to this disorder? Make sure that you select a different medical condition than your peers. Include the name of the medical condition in the subject line so that the medical condition can be followed. Include your references in APA style.

REPLY TO DISCUSSION

Vanessa Brown

Posted Date

Apr 10, 2022, 10:16 PM(edited)

Read

Replies to Vanessa Brown

Diverticulitis

Diverticulitis is the inflammation or infection of diverticula that are most commonly found in the lower part of the large intestine (Mayo Clinic, n.d.). Diverticula are small pouches that can form within the areas of weakened lining of the digestive tract, most commonly in the colon (Mayo Clinic, n.d.). Diverticulitis occurs when there is a tear in a diverticula, and the inflammation or infection cause severe abdominal pain, nausea, vomiting, fever, and a change in bowel habits (Mayo Clinic, n.d.). The treatments can include bowel rest, lifestyle changes (including diet), and antibiotics. In some extreme and/or recurring cases of diverticulitis, surgery is necessary. Some of the risk factors for developing diverticulitis are age, lack of exercise, obesity, smoking, diet high in fat and low in fiber, and certain medications (NSAIDs, steroids, opioids). NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

References

Mayo Clinic. (n.d.). Diverticulitis. Mayoclinic.org. https://www.mayoclinic.org/diseases-conditions/diverticulitis/symptoms-causes/syc-20371758

Topic 6 DQ 2

Apr 7-11, 2022

Select a medication used in evidence-based treatment guidelines for the condition chosen in the first discussion question. Share the mechanism of action of this medication and hints for monitoring, side effects, and drug interactions of which one should be aware. Make sure that you select a different medication than your peers. Include the name of the medication in the subject line so that the medications can be followed. Include your references in APA style.

REPLY TO DISCUSSION

Vanessa Brown

Posted Date

Apr 11, 2022, 11:13 PM

Read

Replies to Vanessa Brown

Metronidazole

Metronidazole (Flagyl) is a part of the antibiotic treatment that can be used with treating diverticulitis. It can be given orally or intravenously for this purpose. The mechanism of action of metronidazole is that it “diffuses into the organism, inhibits protein synthesis by interacting with DNA and causing a loss of helical DNA structure and strand breakage. Therefore, it causes cell death in susceptible organisms” (Weir & Le, 2021). While a patient is taking this medication for an extended period of time, labs such as a CBC w/differential should be monitored for changes (especially elderly or those with renal/hepatic issues), observe for new onset of neurological symptoms, severe or bloody diarrhea (possible C. Diff infection), and monitor for other possible adverse effects (Weir & Le, 2021). Some side effects that may occur are nausea, vomiting, metallic taste in the mouth, dry mouth, diarrhea, or headache. Some drug interactions that need to be discussed are the use of alcohol or alcohol containing medications, lithium, glucocorticoids, and warfarin. The alcohol will cause a serious disulfiram-like reaction, lithium excretion by the kidneys would be compromised, oxidative metabolism of the metronidazole is caused by the glucocorticoids, and the metabolism of warfarin is inhibited with metronidazole (Weir & Le, 2021). NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

References

Weir, C., & Le, J. (2021). Metronidazole. NCBI. https://www.ncbi.nlm.nih.gov/books/NBK539728/

Topic 7 DQ 1

Apr 14-16, 2022

Choose a medical condition from the neurological, musculoskeletal, or integumentary system and explain the pathophysiology changes that may occur. What patient education would need to be included related to this disorder? Make sure that you select a different medical condition than your peers. Include the name of the medical condition in the subject line so that the medical condition can be followed. Include your references in APA style.

REPLY TO DISCUSSION

Nicole Santos

Posted Date

Apr 18, 2022, 9:26 PM

Read

Replies to Nicole Santos

Alopecia Areata

Alopecia areata is an autoimmune condition where the body attacks its hair follicles, causing hair loss anywhere on the body. The hair loss typically occurs in circular patches that may overlap. It is important to educate the patient on the root cause of their diagnosis and their treatment options available to them. It is also important to educate proper diet of 0.8 grams of protein per kilogram of body weight and discontinuing medications that may affect hair growth. You can also offer support and counseling to help with coping with hair loss. Suggesting various styling techniques and hair colors can also help in reducing the appearance of thinning hair volume and assist with coping.

References

Hair loss types: Alopecia areata overview. American Academy of Dermatology. (2022). Retrieved April 18, 2022, from https://www.aad.org/public/diseases/hair-loss/types/alopecia

Mims. (n.d.). Alopecia patient education. MIMS Malaysia. Retrieved April 18, 2022, from https://specialty.mims.com/alopecia/patient%20education

Topic 7 DQ 2

Apr 14-18, 2022

REPLY TO DISCUSSION

Nicole Santos

Posted Date

Apr 18, 2022, 9:47 PM

Read

Replies to Nicole Santos

Minoxidil

Minoxidil, or more commonly known as Rogaine, is a well known treatment for alopecia areata. Minoxidil helps increase blood supply and nutrients to the hair follicles, helping to strengthen existing hair follicles and promoting hair growth. Some common side effects of minoxidil are irritation, eczema, abnormal hair growth on the body, redness at application site, burning, worsening hair loss. It is cautioned that one minoxidil is used, it should be used indefinitely, with apparent hair growth within a minimum of four months; avoid contact with scalp once it is applied as it can easily be rubbed off; may experience change in hair color; avoid in patients with heart issues; avoid contact with eyes.

Reference

Goren, A., Naccarato, T., Situm, M., Kovacevic, M., Lotti, T., & McCoy, J. (2017). Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation. Journal of biological regulators and homeostatic agents, 31(4), 1049–1053.

Cristina Alimon

Posted Date

Apr 18, 2022, 9:16 PM

Read

Replies to Nicole Santos

Levodopa (L-Dopa)

Levodopa is a dopamine precursor; it is beneficial for controlling bradykinetic symptoms associated with Parkinson’s disease (PD) and improving the quality of life in people with idiopathic PD (Gandhi KR, 2021). Levodopa may halt the course of Parkinson’s disease or provide further advantages long after the medicine is stopped.

Mechanism of Action

Levodopa is converted to dopamine in both the CNS and the periphery. Inhibitors of dopamine decarboxylase prevent Levodopa from being converted to dopamine in the periphery, allowing more Levodopa to penetrate the Blood-Brain Barrier (Gandhi KR, 2021). Once converted to dopamine, it acts on postsynaptic dopaminergic receptors, compensating for the loss of endogenous dopamine. NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

Hints for monitoring

Individuals using Levodopa must regularly monitor their BUN, creatinine, and hepatic function (Gandhi KR, 2021). A healthy liver is critical for people on Levodopa since it is the site of decarboxylation. When a person has glaucoma, it is also essential to check their intraocular pressure to ensure it is safe. Before and while taking Levodopa, it is also vital to check for peripheral neuropathy to see if it will worsen. Patients should also have their dyskinesia checked regularly. Therefore, it is crucial to watch patients who take dopaminergic medications for psychotic behavior and hallucinations. Hallucinations can happen when people are confused or have many dreams.

Side effects

Taking Levodopa’s most common side effects are nausea, dizziness, headache, and sleepiness. Typical side effects for older people who take Levodopa are confusion, hallucinations, delusions, psychosis, and agitation.

Drug interactions

Levodopa is contraindicated when monoamine oxidase inhibitors (MAOIs) are used concurrently, as this might result in a hypertensive crisis (Gandhi KR, 2021). However, when transitioning from Levodopa to an MAOI or vice versa, a 14-day washout period should be observed. Patients using D2 antagonists may decrease the effects of Levodopa, which may lessen the drug’s positive benefits (Gandhi KR, 2021).

Reference:

Gandhi KR, S. A. (2021, April 30). Levodopa (L-dopa) – StatPearls – NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK482140/

Topic 8 DQ 1

Apr 21-23, 2022

Choose a medical condition from the endocrine system and explain the pathophysiology changes that may occur. What patient education would need to be included related to this disorder? Make sure that you select a different medical condition than your peers. Include the name of the medical condition in the subject line so that the medical condition can be followed. Include your references in APA style.

REPLY TO DISCUSSION

Nicole Santos

Posted Date

Apr 25, 2022, 3:26 PM

Read

Replies to Nicole Santos

GOITER

Goiter is an abnormal growth of the thyroid gland located at the base of the neck. This may present as an enlargement of the thyroid or irregular cell growth that may cause lumps or nodules in the thyroid. Goiter may be a result of change in thyroid hormones or no change at all. Some common causes of goiter is lack of iodine intake from an inidivuduals diet. Depending on the cause of goiter, an individual may exhibit symptoms of hyperthyroidsim or hyperthyroidism. In obstructive goiter, signs and symptoms include difficulties swallowing, labored breathing, hoarseness, cough, and snoring. Treatment of goiter varies on the cause, treating the symptoms and complications. It is important to educate patients with goiter on the cause of their goiter; adequate iodine intake; annual physical exams and neck exams; annual blood work. For patients on medical treatment for goiter, it is important to reinforce the importance of taking prescribed medications as ordered.

Reference

Can AS, Rehman A. Goiter. [Updated 2021 Aug 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562161/

Topic 8 DQ 2

Apr 21-25, 2022

REPLY TO DISCUSSION

Cristina Alimon

Posted Date

Apr 25, 2022, 7:18 PM

Read

Replies to Cristina Alimon

Propylthiouracil (PTU)

Propylthiouracil is used to treat hyperthyroidism (abnormal thyroid activity), Graves’ disease, and toxic goiter (enlarged thyroid). It is also occasionally used to relieve symptoms prior to thyroid surgery or radioactive iodine therapy.

Mechanism of action

Propylthiouracil suppresses thyroid hormone synthesis. It works by blocking thyroid peroxidase, which normally converts iodide to iodine and integrates it into tyrosine (Amisha & Rehman, 2021). The primary components of thyroxine (T4) and triiodothyronine (T3) are not formed (T3). It inhibits T4 to T3 conversion peripherally. It affects thyroid hormones in the thyroid gland or in the blood.

Hints of monitoring

Thyroid function tests should be monitored while on PTU treatment. Patients using warfarin must also have their prothrombin time monitored. PTU treatment includes patient education and counseling. The patient should be advised: Notify your doctor if you become pregnant or plan to become pregnant while taking the medicine. Report any fever, drug eruptions, or infection to your doctor. Notify your doctor if you have nausea, right upper quadrant discomfort, or jaundice. Agranulocytosis symptoms include sore throat, fever, chills, gum or skin infections (Amisha & Rehman, 2021). Severe hypotension is another symptom.

Side effects

Symptoms of an allergic response (hives, difficulty breathing, swelling of the face or throat) (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling). Propylthiouracil harms the liver (especially during the first 6 months of treatment). If you suffer nausea, vomiting, upper stomach discomfort, itching, fever, fatigue, lack of appetite, dark urine, clay-colored feces, or jaundice, stop taking propylthiouracil and notify your doctor (yellowing of the skin or eyes).

Drug Interactions

Digoxin (digitalis); theophylline; heart or blood pressure medicine; or a blood thinner—warfarin, Coumadin, Jantoven—all have drug interactions with Propylthiouracil.

References

Amisha, F., & Rehman, A. (2021, July 11). Propylthiouracil (PTU) – StatPearls – NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK549828/

Cerner Multum. (2021, June 11). Propylthiouracil. Drugs.com. https://www.drugs.com/mtm/propylthiouracil.html

Topic 2 Content Lesson Presentation

REVIEW ASSIGNMENT

Start Date

Mar 10, 2022, 12:00 AM

Due Date

Mar 16, 2022, 11:59 PM

Points

167

Rubric

View Rubric

Status

Published

Assessment Description

Create an 8-9 slide presentation with speaker notes about a selected disease process and drug class. The presentation should provide content specific information on the selected disease process and drug class for staff or learners in a clinical environment.

Follow these steps:

Select a disease process and a drug class used to treat the disease process.
Describe pharmacokinetics and pharmacodynamics of the drug related to the pathophysiology of the disease process.
Describe the product, its intended use, side effects, adverse reactions, and safety issues.
Identify ethnic, cultural, and genetic differences in patients that may affect the safety or efficacy of medications.
How would you monitor the desired effect is achieved?

Be sure to include three to five references.

While APA style is not required for the body of this assignment, solid academic writing is expected, and documentation of sources should be presented using APA formatting guidelines, which can be found in the APA Style Guide, located in the Student Success Center. NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.

You are not required to submit this assignment to LopesWrite.

Content Lesson Presentation – Rubric

Collapse All Content Lesson Presentation – RubricCollapse All

Disease Process and Drug Class

25.05 points

Criteria Description

Disease Process and Drug Class

Excellent

25.05 points

A disease process and drug class used to treat the disease process is present.

Good

23.05 points

A disease process and drug class used to treat the disease process is presented.

Satisfactory

22.04 points

A disease process and drug class used to treat the disease process is adequately presented.

Less than Satisfactory

20.04 points

A disease process and drug class used to treat the disease process is present, but incomplete or inaccurate.

Unsatisfactory

0 points

A disease process and drug class used to treat the disease process is not present.

Pharmacokinetics and Pharmacodynamics

25.05 points

Criteria Description

Pharmacokinetics and Pharmacodynamics

Excellent

25.05 points

A description of pharmacokinetics and pharmacodynamics of the drug related to the pathophysiology of the disease process is presented in a thoughtful and insightful manner. Supporting material is of exceptional quality and quantity.

Good

23.05 points

A description of pharmacokinetics and pharmacodynamics of the drug related to the pathophysiology of the disease process is adequately presented. Supporting material is of above average quality and quantity.

Satisfactory

22.04 points

A description of pharmacokinetics and pharmacodynamics of the drug related to the pathophysiology of the disease process is adequately presented. Supporting material is of baseline acceptable quality and quantity.

Less than Satisfactory

20.04 points

A description of pharmacokinetics and pharmacodynamics of the drug related to the pathophysiology of the disease process is present, but incomplete or inaccurate.

Unsatisfactory

0 points

A description of pharmacokinetics and pharmacodynamics of the drug related to the pathophysiology of the disease process is not present.

Product

25.05 points

Criteria Description

Product

Excellent

25.05 points

A description of the product, intended use, side effects, adverse reactions, and safety issues is presented in a thoughtful and insightful manner. Supporting material is of exceptional quality and quantity.

Good

23.05 points

A description of the product, intended use, side effects, adverse reactions, and safety issues is adequately presented. Supporting material is of above average quality and quantity.

Satisfactory

22.04 points

A description of the product, intended use, side effects, adverse reactions, and safety issues is adequately presented. Supporting material is of baseline acceptable quality and quantity.

Less than Satisfactory

20.04 points

A description of the product, intended use, side effects, adverse reactions, and safety issues is present, but incomplete or inaccurate.

Unsatisfactory

0 points

A description of the product, intended use, side effects, adverse reactions, and safety issues is not present.

Ethnic, Cultural, and Genetic Differences

25.05 points

Criteria Description

Ethnic, Cultural, and Genetic Differences

Excellent

25.05 points

A description of ethnic, cultural and genetic differences in patients that may affect the safety or efficacy of medications is presented in a thoughtful and insightful manner. Supporting material is of exceptional quality and quantity. NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

Good

23.05 points

A description of ethnic, cultural and genetic differences in patients that may affect the safety or efficacy of medications is adequately presented. Supporting material is of above average quality and quantity.

Satisfactory

22.04 points

A description of ethnic, cultural and genetic differences in patients that may affect the safety or efficacy of medications is adequately presented. Supporting material is of baseline acceptable quality and quantity.

Less than Satisfactory

20.04 points

A description of ethnic, cultural and genetic differences in patients that may affect the safety or efficacy of medications is present, but incomplete or inaccurate.

Unsatisfactory

0 points

A description of ethnic, cultural and genetic differences in patients that may affect the safety or efficacy of medications is not present.

Monitor

25.05 points

Criteria Description

Monitor

Excellent

25.05 points

A description of how you would monitor the desired affect is presented in a thoughtful and insightful manner. Supporting material is of exceptional quality and quantity.

Good

23.05 points

A description of how you would monitor the desired affect is adequately presented. Supporting material is of above average quality and quantity.

Satisfactory

22.04 points

A description of how you would monitor the desired affect is of baseline acceptable quality and quantity.

Less than Satisfactory

20.04 points

A description of how you would monitor the desired affect is present, but incomplete or inaccurate.

Unsatisfactory

0 points

A description of how you would monitor the desired affect is achieved is not present.

Presentation of Content

8.35 points

Criteria Description

Presentation of Content

Excellent

8.35 points

The content is written clearly and concisely. Ideas universally progress and relate to each other. The project includes motivating questions and advanced organizers. The project gives the audience a clear sense of the main idea.

Good

7.68 points

The content is written with a logical progression of ideas and supporting information exhibiting a unity, coherence, and cohesiveness. Includes persuasive information from reliable sources.

Satisfactory

7.35 points

The presentation slides are generally competent, but ideas may show some inconsistency in organization or in their relationships to each other.

Less than Satisfactory

6.68 points

The content is vague in conveying a point of view and does not create a strong sense of purpose. Includes some persuasive information.

Unsatisfactory

0 points

The content lacks a clear point of view and logical sequence of information. Includes little persuasive information. Sequencing of ideas is unclear.

Layout

8.35 points

Criteria Description

Layout

Excellent

8.35 points

The layout is visually pleasing and contributes to the overall message with appropriate use of headings, subheadings, and white space. Text is appropriate in length for the target audience and to the point. The background and colors enhance the readability of the text.

Good

7.68 points

The layout background and text complement each other and enable the content to be easily read. The fonts are easy to read and point size varies appropriately for headings and text.

Satisfactory

7.35 points

The layout uses horizontal and vertical white space appropriately. Sometimes the fonts are easy to read, but in a few places the use of fonts, italics, bold, long paragraphs, color, or busy background detracts and does not enhance readability.

Less than Satisfactory

6.68 points

The layout shows some structure, but appears cluttered and busy or distracting with large gaps of white space or a distracting background. Overall readability is difficult due to lengthy paragraphs, too many different fonts, dark or busy background, overuse of bold, or lack of appropriate indentations of text.

Unsatisfactory

0 points

The layout is cluttered, confusing, and does not use spacing, headings, and subheadings to enhance the readability. The text is extremely difficult to read with long blocks of text, small point size for fonts, and inappropriate contrasting colors. Poor use of headings, subheadings, indentations, or bold formatting is evident.

Language Use and Audience Awareness (includes sentence construction, word choice, etc.)

8.35 points

Criteria Description

Language Use and Audience Awareness (includes sentence construction, word choice, etc.)

Excellent

8.35 points

The writer uses a variety of sentence constructions, figures of speech, and word choice in distinctive and creative ways that are appropriate to purpose, discipline, and scope.

Good

7.68 points

The writer is clearly aware of audience, uses a variety of appropriate vocabulary for the targeted audience, and uses figures of speech to communicate clearly.

Satisfactory

7.35 points

Language is appropriate to the targeted audience for the most part. NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

Less than Satisfactory

6.68 points

Some distracting inconsistencies in language choice (register) or word choice are present. The writer exhibits some lack of control in using figures of speech appropriately.

Unsatisfactory

0 points

Inappropriate word choice and lack of variety in language use are evident. Writer appears to be unaware of audience. Use of primer prose indicates writer either does not apply figures of speech or uses them inappropriately.

Mechanics of Writing (includes spelling, punctuation, grammar, language use)

8.35 points

Criteria Description

Mechanics of Writing (includes spelling, punctuation, grammar, language use)

Excellent

8.35 points

Writer is clearly in control of standard, written, academic English.

Good

7.68 points

Slides are largely free of mechanical errors, although a few may be present.

Satisfactory

7.35 points

Some mechanical errors or typos are present, but they are not overly distracting to the reader.

Less than Satisfactory

6.68 points

Frequent and repetitive mechanical errors distract the reader.

Unsatisfactory

0 points

Slide errors are pervasive enough that they impede communication of meaning.

Documentation of Sources

8.35 points

Criteria Description

Documentation of Sources (citations, footnotes, references, bibliography, etc., as appropriate to assignment and style)

Excellent

8.35 points

Sources are completely and correctly documented, as appropriate to assignment and style, and format is free of error.

Good

7.68 points

Sources are documented, as appropriate to assignment and style, and format is mostly correct.

Satisfactory

7.35 points

Sources are documented, as appropriate to assignment and style, although some formatting errors may be present.

Less than Satisfactory

6.68 points

Documentation of sources is inconsistent or incorrect, as appropriate to assignment and style, with numerous formatting errors.

Unsatisfactory

0 points

Sources are not documented.

Total 167 points

Topic 3 Acid-Base and Electrolyte Case Study

REVIEW ASSIGNMENT

Start Date

Mar 17, 2022, 12:00 AM

Due Date

Mar 23, 2022, 11:59 PM

Points

167

Rubric

View Rubric

Status

Published

Assessment Description

A nurse is taking care of an 85-year-old woman in a hospital-based skilled nursing facility. In the report, the nurse is told the patient has not been breathing well for the past 2 days. She has been lethargic, her skin is warm and dry, and she has a decreased urine output. The following laboratory findings were returned from the laboratory immediately after morning report: NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

Blood Chemistries

Na: 147
Cl: 110
K: 4.0

Arterial Blood Gases

pH: 7.33
PCO2: 48
HCO3: 27
PO2: 96

Urinalysis

Urine Specific Gravity: 1.040

Address the following:

Identify each of the abnormal laboratory findings in the above results. Specify how they differ from a normal range and identify what condition each abnormality indicates.
What specific electrolyte disturbance does the patient have?
What clinical manifestations would the nurse expect to see with this electrolyte abnormality presented above?
If the patient had an increase in her potassium level, for what clinical manifestations would the nurse monitor?
What blood gas abnormality is seen in this patient? Discuss the rationale for your answer.
What are the three major mechanisms of pH regulation?

This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.

You are not required to submit this assignment to LopesWrite.

Acid-Base and Electrolyte Case Study – Rubric

Collapse All Acid-Base And Electrolyte Case Study – RubricCollapse All

Identification of Abnormalities

25.05 points

Criteria Description

Identification of Abnormalities

5: Excellent 93-100%

25.05 points

Identification of the abnormal laboratory findings is accurate, supplemented by a detailed and thorough identification of the conditions each abnormality indicates.

4: Good 89-92%

23.05 points

Identification of the abnormal laboratory findings and their respective conditions is accurate.

3: Satisfactory 81-88%

22.04 points

Identification of the abnormal laboratory findings and their respective conditions is mostly correct but is missing key specifics.

2: Less Than Satisfactory 76-80%

20.04 points

Identification of the abnormal laboratory findings and their respective conditions is incorrect and/or incomplete.

1: Unsatisfactory 0-75%

0 points

Identification of the abnormal laboratory findings and their respective conditions is not included.

Identification of Electrolyte Disturbance

25.05 points

Criteria Description

Identification of Electrolyte Disturbance

5: Excellent 93-100%

25.05 points

Identification of the electrolyte disturbance is correct.

4: Good 89-92%

23.05 points

N/A

3: Satisfactory 81-88%

22.04 points

N/A

2: Less Than Satisfactory 76-80%

20.04 points

Identification of the electrolyte disturbance is incorrect.

1: Unsatisfactory 0-75%

0 points

Identification of the electrolyte disturbance is not included.

Electrolyte Abnormality Clinical Manifestations

25.05 points

Criteria Description

Electrolyte Abnormality Clinical Manifestations

5: Excellent 93-100%

25.05 points

Identification of electrolyte abnormality clinical manifestations is accurate, supported by thorough and detailed insight.

4: Good 89-92%

23.05 points

Identification of electrolyte abnormality clinical manifestations is accurate.

3: Satisfactory 81-88%

22.04 points

Identification of electrolyte abnormality clinical manifestations is mostly correct but is missing key symptoms.

2: Less Than Satisfactory 76-80%

20.04 points

Identification of electrolyte abnormality clinical manifestations is incorrect and/or incomplete.

1: Unsatisfactory 0-75%

0 points

Identification of electrolyte abnormality clinical manifestations is not included.

Increased Potassium Clinical Manifestations

25.05 points

Criteria Description

Increased Potassium Clinical Manifestations

5: Excellent 93-100%

25.05 points

Identification of increased potassium level clinical manifestations is accurate, supported by detailed and thorough insight.

4: Good 89-92%

23.05 points

Identification of increased potassium level clinical manifestations is accurate.

3: Satisfactory 81-88%

22.04 points

Identification of increased potassium level clinical manifestations is mostly correct but is missing key symptoms.

2: Less Than Satisfactory 76-80%

20.04 points

Identification of increased potassium level clinical manifestations is incorrect and/or incomplete.

1: Unsatisfactory 0-75%

0 points

Identification of increased potassium level clinical manifestations is not included.

Blood Gas Abnormality

25.05 points

Criteria Description

Blood Gas Abnormality

5: Excellent 93-100%

25.05 points

Assessment of blood gas abnormality is accurate, supported by a detailed and thorough discussion of the patient’s condition.

4: Good 89-92%

23.05 points

Assessment of blood gas abnormality is accurate.

3: Satisfactory 81-88%

22.04 points

Assessment of blood gas abnormality is mostly correct but is missing key specifics.

2: Less Than Satisfactory 76-80%

20.04 points

Assessment of blood gas abnormality is incorrect and/or incomplete.

1: Unsatisfactory 0-75%

0 points

Assessment of blood gas abnormality is not included.

Mechanisms of pH Regulation

25.05 points

Criteria Description

Mechanisms of pH Regulation

5: Excellent 93-100%

25.05 points

The three major mechanisms of pH regulation are accurately identified, and the properties of each mechanism are briefly described. NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

4: Good 89-92%

23.05 points

The three major mechanisms of pH regulation are accurately identified.

3: Satisfactory 81-88%

22.04 points

The three major mechanisms of pH regulation are mostly correct.

2: Less Than Satisfactory 76-80%

20.04 points

The three major mechanisms of pH regulation are incorrect and/or incomplete.

1: Unsatisfactory 0-75%

0 points

The three major mechanisms of pH regulation are not addressed.

Mechanics of Writing (includes spelling, punctuation, grammar, and language use)

8.35 points

Criteria Description

Mechanics of Writing (includes spelling, punctuation, grammar, and language use)

5: Excellent 93-100%

8.35 points

The writer is clearly in command of standard, written, academic English.

4: Good 89-92%

7.68 points

Prose is largely free of mechanical errors, although a few may be present. The writer uses a variety of effective sentence structures and figures of speech.

3: Satisfactory 81-88%

7.35 points

Some mechanical errors or typos are present, but they are not overly distracting to the reader. Correct and varied sentence structure and audience-appropriate language are employed.

2: Less Than Satisfactory 76-80%

6.68 points

Frequent and repetitive mechanical errors distract the reader. Inconsistencies in language choice (register) or word choice are present. Sentence structure is correct but not varied.

1: Unsatisfactory 0-75%

0 points

Surface errors are pervasive enough that they impede communication of meaning. Inappropriate word choice or sentence construction is employed.

Documentation of Sources

8.35 points

Criteria Description

Documentation of Sources (citations, footnotes, references, bibliography, etc., as appropriate to assignment and style)

5: Excellent 93-100%

8.35 points

Sources are completely and correctly documented, as appropriate to assignment and style, and format is free of error.

4: Good 89-92%

7.68 points

Sources are documented, as appropriate to assignment and style, and format is mostly correct.

3: Satisfactory 81-88%

7.35 points

Sources are documented, as appropriate to assignment and style, although some formatting errors may be present.

2: Less Than Satisfactory 76-80%

6.68 points

Documentation of sources is inconsistent or incorrect, as appropriate to assignment and style, with numerous formatting errors.

1: Unsatisfactory 0-75%

0 points

Sources are not documented.

Total 167 points

Topic 6 CLC – Staff Training

GO TO GROUP

Start Date

Apr 7, 2022, 12:00 AM

Due Date

Apr 13, 2022, 11:59 PM

Points

176

Rubric

View Rubric

Status

Published

Assessment Traits

Group

Requires Lopeswrite

Assessment Description

This is a Collaborative Learning Community (CLC) assignment.

This assignment requires completion of two parts: a presentation and an educational resource.

Part 1: Presentation

Create a PowerPoint presentation (15-20 slides, with speaker notes) for a staff training meeting on the pathophysiology and pharmacologic agents for a select disease process.

Each CLC will choose one disease process from the following list and obtain instructor approval to avoid duplication:

Alzheimer’s Disease
Asthma
Diabetes Type 2
Epilepsy
Gastroesophageal Reflux Disease (GERD)
Hypertension
Hypothyroidism
Multiple Sclerosis
Peptic Ulcer Disease
Tuberculosis

Describe the physiology and pathophysiology of the disease, clinical manifestations, and evaluation (e.g., labs, imaging). NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

Describe the pharmacologic treatment of the disease, including pharmacokinetics, pharmacodynamics, drug interactions, side effects, adverse reactions, and application of the nursing process in monitoring the drug therapy.

Part 2: Educational Resource

Using your selected disease process from Part 1, develop an educational resource that can assist staff in increasing patient knowledge of medications and medication compliance.

The vehicle for your educational resource could include pamphlets, handouts, or any other brief, concise medium to convey the information to staff.

General Requirements

Refer to the resource, “Creating Effective PowerPoint Presentations,” located in the Student Success Center, for additional guidance on completing this assignment in the appropriate style.

This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.

You are required to submit this assignment to LopesWrite. A link to the LopesWrite technical support articles is located in Class Resources if you need assistance.

CLC – Staff Training – Rubric

Collapse All CLC – Staff Training – RubricCollapse All

Physiology and Pathophysiology

26.4 points

Criteria Description

Physiology and Pathophysiology

5: Excellent 93-100%

26.4 points

A description of physiology and pathophysiology of the disease, clinical manifestations, and evaluation is present. Supporting material is of exceptional quality and quantity.

4: Good 89-92%

24.29 points

A description of physiology and pathophysiology of the disease, clinical manifestations, and evaluation is presented. Supporting material is of above average quality and quantity.

3: Satisfactory 81-88%

23.23 points

A description of physiology and pathophysiology of the disease, clinical manifestations, and evaluation is adequately presented.

2: Less Than Satisfactory 76-80%

21.12 points

A description of physiology and pathophysiology of the disease, clinical manifestations, and evaluation is present, but incomplete or inaccurate.

1: Unsatisfactory 0-75%

0 points

A description of physiology and pathophysiology of the disease, clinical manifestations, and evaluation is not present.

Pharmacologic Treatment

26.4 points

Criteria Description

Pharmacologic Treatment

5: Excellent 93-100%

26.4 points

A description of pharmacologic treatment of the disease, including pharmacokinetics, pharmacodynamics, drug interactions, side effects, adverse reactions, and application of the nursing process in monitoring drug therapy is presented in a thoughtful and insightful manner. Supporting material is of exceptional quality and quantity.

4: Good 89-92%

24.29 points

A description of pharmacologic treatment of the disease, including pharmacokinetics, pharmacodynamics, drug interactions, side effects, adverse reactions, and application of the nursing process in monitoring drug therapy is adequately presented. Supporting material is of above average quality and quantity.

3: Satisfactory 81-88%

23.23 points

A description of pharmacologic treatment of the disease, including pharmacokinetics, pharmacodynamics, drug interactions, side effects, adverse reactions, and application of the nursing process in monitoring drug therapy is adequately presented. Supporting material is of baseline acceptable quality and quantity.

2: Less Than Satisfactory 76-80%

21.12 points

A description of pharmacologic treatment of the disease, including pharmacokinetics, pharmacodynamics, drug interactions, side effects, adverse reactions, and application of the nursing process in monitoring drug therapy is present, but incomplete or inaccurate. NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems

1: Unsatisfactory 0-75%

0 points

Educational Resource

26.4 points

Criteria Description

Educational Resource

5: Excellent 93-100%

26.4 points

An educational resource that can assist staff in increasing patient knowledge of medications and medication compliance is presented in a thoughtful and insightful manner. Supporting material is of exceptional quality and quantity.

4: Good 89-92%

24.29 points

An educational resource that can assist staff in increasing patient knowledge of medications and medication compliance is adequately presented. Supporting material is of above average quality and quantity.

3: Satisfactory 81-88%

23.23 points

An educational resource that can assist staff in increasing patient knowledge of medications and medication compliance is adequately presented. Supporting material is of baseline acceptable quality and quantity.

2: Less Than Satisfactory 76-80%

21.12 points

An educational resource that can assist staff in increasing patient knowledge of medications and medication compliance is present, but incomplete or inaccurate.

1: Unsatisfactory 0-75%

0 points

An educational resource that can assist staff in increasing patient knowledge of medications and medication compliance is not present.

Presentation of Content

26.4 points

Criteria Description

Presentation of Content

5: Excellent 93-100%

26.4 points

4: Good 89-92%

24.29 points

The content is written with a logical progression of ideas and supporting information exhibiting a unity, coherence, and cohesiveness. Includes persuasive information from reliable sources.

3: Satisfactory 81-88%

23.23 points

The presentation slides are generally competent, but ideas may show some inconsistency in organization or in their relationships to each other.

2: Less Than Satisfactory 76-80%

21.12 points

The content is vague in conveying a point of view and does not create a strong sense of purpose. Includes some persuasive information.

1: Unsatisfactory 0-75%

0 points

The content lacks a clear point of view and logical sequence of information. Includes little persuasive information. Sequencing of ideas is unclear.

Layout

26.4 points

Criteria Description

Layout

5: Excellent 93-100%

26.4 points

4: Good 89-92%

24.29 points

The layout background and text complement each other and enable the content to be easily read. The fonts are easy to read and point size varies appropriately for headings and text.

3: Satisfactory 81-88%

23.23 points

2: Less Than Satisfactory 76-80%

21.12 points

1: Unsatisfactory 0-75%

0 points

Language Use and Audience Awareness (includes sentence construction, word choice, etc.)

8.8 points

Criteria Description

Language Use and Audience Awareness (includes sentence construction, word choice, etc.)

5: Excellent 93-100%

8.8 points

The writer uses a variety of sentence constructions, figures of speech, and word choice in distinctive and creative ways that are appropriate to purpose, discipline, and scope.

4: Good 89-92%

8.1 points

The writer is clearly aware of audience, uses a variety of appropriate vocabulary for the targeted audience, and uses figures of speech to communicate clearly.

3: Satisfactory 81-88%

7.74 points

Language is appropriate to the targeted audience for the most part.

2: Less Than Satisfactory 76-80%

7.04 points

Some distracting inconsistencies in language choice (register) or word choice are present. The writer exhibits some lack of control in using figures of speech appropriately.

1: Unsatisfactory 0-75%

0 points

Mechanics of Writing (includes spelling, punctuation, grammar, language use)

17.6 points

Criteria Description

Mechanics of Writing (includes spelling, punctuation, grammar, language use)

5: Excellent 93-100%

17.6 points

Writer is clearly in control of standard, written, academic English.

4: Good 89-92%

16.19 points

Slides are largely free of mechanical errors, although a few may be present.

3: Satisfactory 81-88%

15.49 points

Some mechanical errors or typos are present, but they are not overly distracting to the reader.

2: Less Than Satisfactory 76-80%

14.08 points

Frequent and repetitive mechanical errors distract the reader.

1: Unsatisfactory 0-75%

0 points

Slide errors are pervasive enough that they impede communication of meaning.

Documentation of Sources

17.6 points

Criteria Description

Documentation of Sources (citations, footnotes, references, bibliography, etc., as appropriate to assignment and style)

5: Excellent 93-100%

17.6 points

Sources are completely and correctly documented, as appropriate to assignment and style, and format is free of error.

4: Good 89-92%

16.19 points

Sources are documented, as appropriate to assignment and style, and format is mostly correct.

3: Satisfactory 81-88%

15.49 points

Sources are documented, as appropriate to assignment and style, although some formatting errors may be present.

2: Less Than Satisfactory 76-80%

14.08 points

Documentation of sources is inconsistent or incorrect, as appropriate to assignment and style, with numerous formatting errors.

1: Unsatisfactory 0-75%

0 points

Sources are not documented.

NUR 641E Topic 6: Gastrointestinal And Genitourinary Systems